<VariationArchive VariationID="821274" VariationName="NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup)" VariationType="Duplication" Accession="VCV000821274" Version="12" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-29" DateCreated="2018-05-21" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="809572" VariationID="821274">
      <GeneList>
        <Gene Symbol="LOC100507346" FullName="uncharacterized LOC100507346" GeneID="100507346" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q22.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="95463609" stop="95470019" display_start="95463609" display_stop="95470019" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PTCH1" FullName="patched 1" GeneID="5727" HGNC_ID="HGNC:9585" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q22.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="95442980" stop="95516971" display_start="95442980" display_stop="95516971" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="98205263" stop="98279246" display_start="98205263" display_stop="98279246" Strand="-" />
          </Location>
          <OMIM>601309</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PTCH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PTCH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup)</Name>
      <CanonicalSPDI>NC_000009.12:95467229:GGATATTCGGG:GGATATTCGGGATATTCGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q22.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="95467229" stop="95467230" display_start="95467229" display_stop="95467230" variantLength="9" positionVCF="95467229" referenceAlleleVCF="T" alternateAlleleVCF="TGGATATTCG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="98229511" stop="98229512" display_start="98229511" display_stop="98229512" variantLength="9" positionVCF="98229511" referenceAlleleVCF="T" alternateAlleleVCF="TGGATATTCG" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000264.3" sequenceAccession="NM_000264" sequenceVersion="3" change="c.2438_2446dup">
            <Expression>NM_000264.3:c.2438_2446dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.98229514_98229522dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.98229514_98229522dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.95467232_95467240dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.95467232_95467240dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007664.1" sequenceAccession="NG_007664" sequenceVersion="1" change="g.54728_54736dup">
            <Expression>NG_007664.1:g.54728_54736dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000264.5" sequenceAccession="NM_000264" sequenceVersion="5" change="c.2438_2446dup" MANESelect="true">
            <Expression>NM_000264.5:c.2438_2446dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000255.2" sequenceAccession="NP_000255" sequenceVersion="2" change="p.Pro813_Ile815dup">
            <Expression>NP_000255.2:p.Pro813_Ile815dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083602.3" sequenceAccession="NM_001083602" sequenceVersion="3" change="c.2240_2248dup">
            <Expression>NM_001083602.3:c.2240_2248dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077071.1" sequenceAccession="NP_001077071" sequenceVersion="1" change="p.Pro747_Ile749dup">
            <Expression>NP_001077071.1:p.Pro747_Ile749dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083603.3" sequenceAccession="NM_001083603" sequenceVersion="3" change="c.2435_2443dup" MANEPlusClinical="true">
            <Expression>NM_001083603.3:c.2435_2443dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077072.1" sequenceAccession="NP_001077072" sequenceVersion="1" change="p.Pro812_Ile814dup">
            <Expression>NP_001077072.1:p.Pro812_Ile814dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083604.3" sequenceAccession="NM_001083604" sequenceVersion="3" change="c.1985_1993dup">
            <Expression>NM_001083604.3:c.1985_1993dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077073.1" sequenceAccession="NP_001077073" sequenceVersion="1" change="p.Pro662_Ile664dup">
            <Expression>NP_001077073.1:p.Pro662_Ile664dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083605.3" sequenceAccession="NM_001083605" sequenceVersion="3" change="c.1985_1993dup">
            <Expression>NM_001083605.3:c.1985_1993dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077074.1" sequenceAccession="NP_001077074" sequenceVersion="1" change="p.Pro662_Ile664dup">
            <Expression>NP_001077074.1:p.Pro662_Ile664dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083606.3" sequenceAccession="NM_001083606" sequenceVersion="3" change="c.1985_1993dup">
            <Expression>NM_001083606.3:c.1985_1993dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077075.1" sequenceAccession="NP_001077075" sequenceVersion="1" change="p.Pro662_Ile664dup">
            <Expression>NP_001077075.1:p.Pro662_Ile664dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001083607.3" sequenceAccession="NM_001083607" sequenceVersion="3" change="c.1985_1993dup">
            <Expression>NM_001083607.3:c.1985_1993dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001077076.1" sequenceAccession="NP_001077076" sequenceVersion="1" change="p.Pro662_Ile664dup">
            <Expression>NP_001077076.1:p.Pro662_Ile664dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354918.2" sequenceAccession="NM_001354918" sequenceVersion="2" change="c.2282_2290dup">
            <Expression>NM_001354918.2:c.2282_2290dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341847.1" sequenceAccession="NP_001341847" sequenceVersion="1" change="p.Pro761_Ile763dup">
            <Expression>NP_001341847.1:p.Pro761_Ile763dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149061.2" sequenceAccession="NR_149061" sequenceVersion="2" change="n.3177_3185dup">
            <Expression>NR_149061.2:n.3177_3185dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_515" sequenceAccession="LRG_515">
            <Expression>LRG_515:g.54728_54736dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_515t1" sequenceAccession="LRG_515t1">
            <Expression>LRG_515t1:c.2438_2446dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000264.3" sequenceAccession="NM_000264" sequenceVersion="3" change="c.2438_2446dup9">
            <Expression>NM_000264.3:c.2438_2446dup9</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601309.0001" DB="OMIM" />
        <XRef Type="rs" ID="1588568813" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup) AND Hereditary cancer-predisposing syndrome" Accession="RCV001015535" Version="3">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup) AND Gorlin syndrome" Accession="RCV001072024" Version="7">
        <ClassifiedConditionList TraitSetID="940">
          <ClassifiedCondition DB="MedGen" ID="C0004779">Gorlin syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup) AND PTCH1-related disorder" Accession="RCV004553555" Version="1">
        <ClassifiedConditionList TraitSetID="74544">
          <ClassifiedCondition>PTCH1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000264.5(PTCH1):c.2438_2446dup (p.Pro813_Ile815dup) AND Basal cell nevus syndrome 1" Accession="RCV004576978" Version="1">
        <ClassifiedConditionList TraitSetID="93531">
          <ClassifiedCondition DB="MedGen" ID="CN376810">Basal cell nevus syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-26" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-05-21" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8658145</ID>
        </Citation>
        <DescriptionHistory Dated="2024-03-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-08-07">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-08-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-01-30">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="74544" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="62374" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PTCH1-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PTCH1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">PTCH1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="940" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="381" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Gorlin syndrome</ElementValue>
                <XRef ID="69408002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Basal cell nevus syndrome</ElementValue>
                <XRef ID="UWMG_1854558" DB="CSER _CC_NCGL, University of Washington" />
                <XRef Type="Phenotypic series" ID="PS109400" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Nevoid basal cell carcinoma syndrome (NBCCS) is characterized by the development of multiple jaw keratocysts, frequently beginning in the second decade of life, and/or basal cell carcinomas (BCCs) usually from the third decade onward. Approximately 60% of individuals have a recognizable appearance with macrocephaly, frontal bossing, coarse facial features, and facial milia. Most individuals have skeletal anomalies (e.g., bifid ribs, wedge-shaped vertebrae). Ectopic calcification, particularly in the falx, is present in more than 90% of affected individuals by age 20 years. Cardiac and ovarian fibromas occur in approximately 2% and 20% of individuals respectively. Approximately 5% of all children with NBCCS develop medulloblastoma (primitive neuroectodermal tumor), generally the desmoplastic subtype. The risk of developing medulloblastoma is substantially higher in individuals with an SUFU pathogenic variant (33%) than in those with a PTCH1 pathogenic variant (&lt;2%). Peak incidence is at age one to two years. Life expectancy in NBCCS is not significantly different from average.</Attribute>
                <XRef ID="NBK1151" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7166" />
                <XRef ID="7166" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301330</ID>
                <ID Source="BookShelf">NBK1151</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21304560</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="377" DB="Orphanet" />
              <XRef ID="C0004779" DB="MedGen" />
              <XRef ID="MONDO:0007187" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS109400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="93531" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="72999" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GORLIN-GOLTZ SYNDROME</ElementValue>
                <XRef Type="MIM" ID="109400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="109400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Basal cell nevus syndrome 1</ElementValue>
                <XRef ID="MONDO:0958174" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BCNS</ElementValue>
                <XRef Type="MIM" ID="109400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NBCCS</ElementValue>
                <XRef Type="MIM" ID="109400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BCNS1</ElementValue>
                <XRef Type="MIM" ID="109400" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301330</ID>
                <ID Source="BookShelf">NBK1151</ID>
              </Citation>
              <XRef ID="CN376810" DB="MedGen" />
              <XRef ID="MONDO:0958174" DB="MONDO" />
              <XRef Type="MIM" ID="109400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28903" SubmissionDate="2018-05-18" DateLastUpdated="2023-04-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601309.0001_BASAL CELL NEVUS SYNDROME 1" title="PTCH1, 9-BP INS, CODON 815, PRO-ASN-ILE INS_BASAL CELL NEVUS SYNDROME 1" />
        <ClinVarAccession Accession="SCV000028903" DateUpdated="2023-04-30" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-06-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 49-year-old man with basal cell nevus syndrome (BCNS1; 109400), Johnson et al. (1996) identified a 9-bp insertion (CCGAATATC) in the PTCH gene. The heterozygous mutation results in the insertion of proline, asparagine, and isoleucine after codon 815 in exon 15 of the gene and is a tandem duplication of 3 amino acids of the normal polypeptide. The patient's affected sister and daughter had the same alteration, but 3 unaffected relatives did not.</Attribute>
              <Citation>
                <ID Source="PubMed">8658145</ID>
              </Citation>
              <XRef DB="OMIM" ID="109400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTCH1" />
          </GeneList>
          <Name>PTCH1, 9-BP INS, CODON 815, PRO-ASN-ILE INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP INS, CODON 815, PRO-ASN-ILE INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601309.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BASAL CELL NEVUS SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2403057" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4880956|MedGen:C0004779" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001237367" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8658145</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 821274). This variant is also known as an insertion of 9 base pairs at nucleotide 2445. This variant has been observed in individuals with basal cell nevus syndrome (PMID: 8658145; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). This variant, c.2438_2446dup, results in the insertion of 3 amino acid(s) to the PTCH1 protein (p.Pro813_Ile815dup), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.98229511_98229512insGGATATTCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004779" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8828084" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3566207|PTCH1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004743745" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PTCH1 c.2438_2446dup9 variant is predicted to result in an in-frame duplication (p.Pro813_Ile815dup). This variant was reported in an individual with basal cell nevus syndrome, and segregated with disease in two additional affected and three unaffected family members (described as occurring at nucleotide 2445, Johnson et al 1996. PubMed ID: 8658145). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating it is rare. In ClinVar, this variant is interpreted as pathogenic and likely pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/821274/). This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000264.3:c.2438_2446dup9</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PTCH1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2316370" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="a564174|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001176380" DateUpdated="2024-05-01" DateCreated="2020-03-16" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8658145</ID>
          </Citation>
          <Comment>The c.2438_2446dupCGAATATCC variant (also known as p.P813_I815dup), located in coding exon 15 of the PTCH1 gene, results from an in-frame duplication of CGAATATCC at nucleotide positions 2438 to 2446. This results in the duplication of 3 extra residues (PNI) between codons 813 and 815. This alteration has been reported in individuals with personal and family history consistent with Nevoid Basal Cell Carcinoma Syndrome (Johnson RL et al. Science, 1996 Jun;272:1668-71; Ambry Internal Data). This amino acid region is not well conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PTCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000264.3:c.2438_2446dupCGAATATCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2403057" TraitType="Disease" MappingType="XRef" MappingValue="C0004779" MappingRef="MedGen">
        <MedGen CUI="C0004779" Name="Gorlin syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8828084" TraitType="Disease" MappingType="Name" MappingValue="PTCH1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PTCH1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28903" TraitType="Disease" MappingType="Name" MappingValue="BASAL CELL NEVUS SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="CN376810" Name="Basal cell nevus syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2316370" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

